| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |